Patient info Open main menu

BOOTS SORE MOUTH PASTILLES - summary of medicine characteristics

Dostupné balení:

Summary of medicine characteristics - BOOTS SORE MOUTH PASTILLES

SUMMARY OF PRODUCT CHARACTERISTICS

1 NAME OF THE MEDICINAL PRODUCT

Boots Sore Mouth Pastilles

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Active ingredient                         ­mg

2.4 – Dichlorobenzyl alcohol                1.29

3 PHARMACEUTICAL FORM

Deep orange-coloured, pleasantly flavoured, concave-convex, well glazed pastille with corrugations on the upper convex surface.

4 CLINICAL PARTICULARS

4.1 Therapeutic indications

For the symptomatic relief of sore mouths.

4.2. Posology and Method of Administration

Adults and children over 3 years: Allow a pastille to dissolve slowly in the mouth every two or three hours during the day, keeping the pastille near the painful area.

Elderly: There is no need for dosage reduction in the elderly.

For oral administration.

4.3. Contra-indications

Hypersensitivity to any of the ingredients.

4.4. Special Warnings and Precautions for Use

Not recommended for children under 3 years.

Keep all medicines out of the reach of children.

4.5 Interaction with other medicinal products and other forms of interaction

No clinically significant interactions known.

4.6 Pregnancy and lactation

The safety of this product during pregnancy and lactation has not been established but is not considered to constitute a hazard during these periods.

4.7. Effects on Ability to Drive and Use Machines

No adverse effects known.

4.8. Undesirable Effects

Occasional hypersensitivity reactions and soreness of the tongue.

4.9. Overdose

4.9. Overdose

No specific symptoms associated with overdosage, other than nausea, vomiting, diarrhoea and soreness of the tongue. Treatment, if required should be symptomatic.

5 PHARMACOLOGICAL PROPERTIES

5 PHARMACOLOGICAL PROPERTIES

5.1 Pharmacodynamic properties

Dichlorobenzyl alcohol has antiseptic properties.

5.2. Pharmacokinetic Properties

No data available.

5.3. Preclinical Safety Data

5.3. Preclinical Safety Data

There are no preclinical data of relevance to the prescriber which are additional to that already included.

6 PHARMACEUTICAL PARTICULARS

6.1 List of excipients

Silicone antifoam 1510

Glycerin

Annatto WSA acid stab liquid biocon

Purity gum 40 Nat Starch and chemical

Maltitol liquid

Potable water

Adipic acid

Myrrh tincture

Levomenthol natural

Clove leaf oil

Sweet orange oil special IFF

Capol 3073B

6.2. Incompatibilities

Not applicable.

6.3 Shelf life

6.4. Special Precautions for Storage

Store in a dry place below 25°C.

6.5. Nature and Contents of Container

Clear cellulose film coated with nitrocellulose and heat-sealed to form a bag.

Each bag is packed in a cardboard carton.

Pack size: 30g

6.6 Special precautions for disposal

6.6 Special precautions for disposal

None.

7 MARKETING AUTHORISATION HOLDER

The Boots Company PLC

1 Thane Road West

Nottingham

NG2 3AA

8 MARKETING AUTHORISATION NUMBER(S)

PL 00014/5370R

9 DATE OF FIRST AUTHORISATION/RENEWAL OF THEAUTHORISATION

23 January 1990